Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re‐expansion of FLT3 ‐ITD acute myeloid leukaemia
- Submitting institution
-
Cardiff University / Prifysgol Caerdydd
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 106742550
- Type
- D - Journal article
- DOI
-
10.1111/bjh.16665
- Title of journal
- British Journal of Haematology
- Article number
- -
- First page
- 231
- Volume
- 191
- Issue
- 2
- ISSN
- 0007-1048
- Open access status
- Compliant
- Month of publication
- May
- Year of publication
- 2020
- URL
-
https://doi.org/10.1111/bjh.16665
- Supplementary information
-
https://onlinelibrary.wiley.com/doi/10.1111/bjh.16665#support-information-section
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
10
- Research group(s)
-
-
- Citation count
- 0
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
-
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
